EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Drug-Drug Interactions in Polypharmacy: A Retrospective Hospital Study

Hania Javed, Fatima Tahir, Umair Ahmed, Sabahat Zahid, Zainab Ali, Muhammad Adeel Khalid, Abida Shamim

Indus Journal of Bioscience Research · 30.03.2026 · 4 (3) · 125-128

DOI: 10.70749/ijbr.v4i3.3030 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Indus Journal of Bioscience Research, online erschienen am 30.03.2026. Verfasst von Hania Javed und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Polypharmacy is increasingly common in clinical practice and is associated with a higher risk of drug–drug interactions (DDIs), which can lead to adverse drug events, reduced therapeutic efficacy, and increased healthcare burden.

Objective

To determine the prevalence, patterns, and predictors of drug–drug interactions among patients with polypharmacy.

Methods

This retrospective observational study was conducted at Shalamar Hospital, Lahore from September 2025 to January, 2026 , and included 180 adult patients receiving five or more medications. Data were collected from medical records, prescription charts, and electronic databases. Drug–drug interactions were identified using standard interaction databases and classified based on severity and mechanism.

Results

The mean age of patients was 54.6 ± 15.2 years, with 56.7% males. The average number of medications per patient was 7.8 ± 2.1. Drug–drug interactions were identified in 78.9% of patients, with a mean of 2.9 ± 1.6 interactions per patient. Moderate interactions were most common (42.2%), followed by major (21.1%) and minor (15.6%) interactions. Pharmacokinetic interactions accounted for 60.6% of cases. A significant association was observed between DDIs and number of medications (p < 0.001), age ≥60 years (p = 0.02), and presence of ≥3 comorbidities (p = 0.01).

Conclusion

Drug–drug interactions are highly prevalent among patients with polypharmacy, with medication burden and comorbidities being the strongest predictors.

Zitieren

APA

Javed, H., Tahir, F., Ahmed, U., Zahid, S., Ali, Z., Khalid, M. A., & Shamim, A. (2026). Drug-Drug Interactions in Polypharmacy: A Retrospective Hospital Study. Indus Journal of Bioscience Research, 4(3), 125-128. https://doi.org/10.70749/ijbr.v4i3.3030

Vancouver

Javed H, Tahir F, Ahmed U, Zahid S, Ali Z, Khalid MA, et al. Drug-Drug Interactions in Polypharmacy: A Retrospective Hospital Study. Indus Journal of Bioscience Research. 2026;4(3):125-128. doi:10.70749/ijbr.v4i3.3030

BibTeX
@article{Javed2026,
  author = {Javed, Hania and Tahir, Fatima and Ahmed, Umair and Zahid, Sabahat and Ali, Zainab and Khalid, Muhammad Adeel and Shamim, Abida},
  title = {Drug-Drug Interactions in Polypharmacy: A Retrospective Hospital Study},
  journal = {Indus Journal of Bioscience Research},
  year = {2026},
  volume = {4},
  number = {3},
  pages = {125--128},
  doi = {10.70749/ijbr.v4i3.3030}
}
Kostenlos starten →